| 2916.11.00 | 00 | Unsaturated acyclic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives: | | | | |
| 2921.45.25 | 00 | Mixtures of 5- and 8-amino-2-naphthalene- sulfonic acid; 2-Naphthylamine-6-sulfonic acid; and o-Naphthionic acid (1-amino- 2-naphthalene- sulfonic acid) | kg | Free | | 15.4¡é/kg + 60% |
| 2924.21.08 | 00 | 1,1-Dimethyl-3-( α, α, α-trifluoro-¡é/tolyl)urea (Fluometuron) | kg | Free | | 15.4¡é/kg + 40.5% |
| 2929.10.15 | 00 | Mixtures of 2,4- and 2,6-toluenediisocyanates | kg | 6.5% | Free (A*,AU,BH, CA,CL,E,IL,J,JO, MA,MX,P) 0.2¡é/kg + 2.9% (SG) | 15.4¡é/kg + 43.5% |
| 2932.11.00 | 00 | Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.11.00 | 00 | Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.21.00 | 00 | Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.31.00 | 00 | Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.41.00 | 00 | Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2933.52 | | Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: | | | | |
| 2933.52 | | Malonylurea (Barbituric acid) and its salts: | | | | |
| 2933.52.10 | 00 | Malonylurea (barbituric acid) | kg | Free | | 25% |
| 2933.54.00 | 00 | Other derivatives of malonylurea (barbituric acid); salts thereof | kg | 3.7% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P, SG) | 50% |
| 2933.61.00 | 00 | Compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure: | | | | |
| 2934.10 | | Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2934.20 | | Compounds containing in the structure a benzothiazole ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2934.30 | | Compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2935.00.13 | 00 | (5-[2-Chloro-4-(trifluoromethyl)phenoxy]-¡é/(methylsulfonyl)-2-nitrobenzamide) (Fomesafen); N-(2,6-Dichloro-3-methylphenyl)-5-amino-1,3,4- triazole-2-sulfonamide; 2,4-Dichloro-5-sulfamoylbenzoic acid; N-Ethyl-o-toluenesulfonamide; N-Ethyl-p-toluenesulfonamide; 7-(Hexadecylsulfonylamino)-1H-indole; Methyl 5-{[(4,6-dimethoxy-2-pyrimidinyl)amino]- carbonylaminosulfonyl}-3-chloro-1-methyl-1H- pyrazole-4-carboxylate (Halosulfuron methyl); and Mixtures of ortho- and para-toluene sulfonamides | kg | Free | | 15.4¡é/kg + 57.5% |
| 2936 | | Provitamins and vitamins, natural or reproduced by synthesis (including natural concentrates), derivatives thereof used primarily as vitamins, and intermixtures of the foregoing, whether or not in any solvent: | | | | |
| 2936.90.01 | | Other, including proviatmins and natural concentrates | | Free | | 25% |
| 2937 | | Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: | | | | |
| 2937.11.00 | 00 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: | | | | |
| 2937.11.00 | 00 | Somatotropin, its derivatives and structural analogues | g | Free | | 10% |
| 2937.21.00 | | Steroidal hormones, their derivatives and structural analogues: | | | | |
| 2937.31.00 | 00 | Catecholamine hormones, their derivatives and structural analogues: | | | | |
